Glycaemic control with insulin glulisine versus regular human insulin in a basal-bolus regimen in patients with Type 2 diabetes

被引：0
|
作者：
Dailey, G
Rosenstock, J
Moses, R
Ways, K
机构：
[1] Scripps Clin, Div Diabet & endocrinol, La Jolla, CA USA
[2] Dallas Diabet & Endocrine Ctr, Dallas, TX USA
[3] Illawarra Diabet Serv, Wollongong, NSW, Australia
[4] Aventis, Bridgewater, NJ USA
来源：
DIABETOLOGIA | 2004年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
734
引用
收藏
页码：A265 / A266
页数：2
相关论文
共 50 条
  • [41] COST-EFFECTIVENESS OF INSULIN DEGLUDEC/INSULIN ASPART TWICE DAILY VERSUS BASAL-BOLUS FULL REGIMEN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN ALGERIA
    Sellam, Y.
    Malek, R.
    Semrouni, M.
    Belhadj, M.
    Zekri, S.
    Brouri, M.
    Arbouche, Z.
    Nouri, N.
    [J]. VALUE IN HEALTH, 2020, 23 : S511 - S511
  • [42] Switching from a human insulin basal-bolus regimen to insulin analog basal-bolus therapy with insulin detemir/insulin aspart improves glycemic control and reduces hypoglycemic episodes in patients with type 1 diabetes:: Results from German subgroup of the PREDICTIVE™ study
    Maxeiner, Stephan
    Hansen, Jes B.
    Nauck, Michael
    [J]. DIABETES, 2006, 55 : A127 - A127
  • [43] USE OF INSULIN-BOLUS CALCULATOR FREE STYLE INSULINX® IN DIABETES TYPE-1 PATIENTS TREATED WITH BASAL-BOLUS INSULIN REGIMEN
    Delgado, E.
    Tejera, C.
    Bellido, D.
    Morales, F.
    Porca, C.
    Diaz Perez De Madrid, Jose
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2015, 17 : A74 - A74
  • [44] Combining insulin glulisine with basal insulin glargine provides improved glycaemic control in patients with Type 2 diabetes in everyday clinical practice
    Donaubauer, B.
    Ferlinz, K.
    Schreiber, S.
    [J]. DIABETIC MEDICINE, 2008, 25
  • [45] Comparison of Basal-Bolus and Premixed Insulin Regimens in Hospitalized Patients With Type 2 Diabetes
    Bellido, Virginia
    Suarez, Lorena
    Galiana Rodriguez, Maria
    Sanchez, Cecilia
    Dieguez, Marta
    Riestra, Maria
    Casal, Florentino
    Delgado, Elias
    Menendez, Edelmiro
    Umpierrez, Guillermo E.
    [J]. DIABETES CARE, 2015, 38 (12) : 2211 - 2216
  • [46] Pharmacodynamics and pharmacokinetics of insulin glulisine compared with insulin lispro and regular human insulin in patients with Type 2 diabetes
    Kapitza, C
    Becker, RHA
    Frick, AD
    Heise, T
    Rave, K
    [J]. DIABETOLOGIA, 2004, 47 : A265 - A265
  • [47] Insulin detemir and insulin aspart:: A promising basal-bolus regimen for type 2 diabetes (vol 66, pg 193, 2004)
    Raslová, K
    Bogoev, M
    Raz, I
    Leth, G
    Gall, MA
    Hâncu, N
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2006, 72 (01) : 112 - 112
  • [48] Prandial Options to Advance Basal Insulin Glargine Therapy: Testing Lixisenatide Plus Basal Insulin Versus Insulin Glulisine Either as Basal-Plus or Basal-Bolus in Type 2 Diabetes: The GetGoal Duo-2 Trial
    Rosenstock, Julio
    Guerci, Bruno
    Hanefeld, Markolf
    Gentile, Sandro
    Aronson, Ronnie
    Tinahones, Francisco J.
    Roy-Duval, Christine
    Souhami, Elisabeth
    Wardecki, Marek
    Ye, Jenny
    Perfetti, Riccardo
    Heller, Simon
    [J]. DIABETES CARE, 2016, 39 (08) : 1318 - 1328
  • [49] Comparison of canagliflozin and liraglutide as a replacement for bolus insulin in type 2 diabetes patients well-controlled by basal-bolus insulin
    Kumashiro, N.
    Ando, Y.
    Shigiyama, F.
    Igarashi, H.
    Yoshikawa, F.
    Uchino, H.
    Yoshino, H.
    Miyagi, M.
    Ikehara, K.
    Hirose, T.
    [J]. DIABETOLOGIA, 2018, 61 : S126 - S126
  • [50] Intensification of Insulin Therapy for Type 2 Diabetic Patients in Primary Care: Basal-Bolus Regimen Versus Premix Insulin Analogs When and for whom?
    Mosenzon, Ofri
    Raz, Itamar
    [J]. DIABETES CARE, 2013, 36 : S212 - S218
12345